The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance
Diabetes, Metabolic Syndrome and Obesity · 2023-02 · Volume 16 · 425-435
DOI: 10.2147/dmso.s399367 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2023-02. Verfasst von Meiyuan Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Hebei Medical University, Shijiazhuang, People's Republic of China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Hebei Medical University, Shijiazhuang, People's Republic of China.
- Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.
- Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling, Shanghai Pudong Hospital, Shanghai, People's Republic of China.
ORCID-Profile: Meiyuan Dong, Song Wen
Zitieren
APA
Dong, M., Chen, H., Wen, S., Yuan, Y., Yang, L., Li, Y., Yuan, X., Xu, D., & Zhou, L. (2023). The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance. Diabetes, Metabolic Syndrome and Obesity, Volume 16, 425-435. https://doi.org/10.2147/dmso.s399367
Vancouver
Dong M, Chen H, Wen S, Yuan Y, Yang L, Li Y, et al. The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance. Diabetes, Metabolic Syndrome and Obesity. 2023;Volume 16:425-435. doi:10.2147/dmso.s399367
BibTeX
@article{Dong2023,
author = {Dong, Meiyuan and Chen, Huiling and Wen, Song and Yuan, Yue and Yang, Liling and Li, Yanyan and Yuan, Xinlu and Xu, Dongxiang and Zhou, Ligang},
title = {The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2023},
volume = {Volume 16},
pages = {425--435},
doi = {10.2147/dmso.s399367}
}
EUVIMED